Pain Management in Arthtroscopic Shoulder Surgery

Arthroscopic Shoulder Surgery Clinical Trial

— PMSS  

Official title:

Comparison of the Effects Combined Suprascapular and Infraclavicular Nerve Blocks to Interscalene Nerve Block Applied Arthtroscopic Shoulder Surgery

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04101266
• Other study ID #: 59/13
• Status: Completed
• Phase: N/A
• Start date: September 30, 2019
• Est. completion date: April 1, 2020

Study information

• Verified date: June 2021
• Source: Diskapi Yildirim Beyazit Education and Research Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

It is compared that combined suprascapular and infraclavicular nerve blocks to interscalene nerve block for clinical outcomes after shoulder surgery

Description:

In this study, the investigators planned to investigate postoperative pain, analgesic dosage, respiratory effects of the block and side effects of patients undergoing general anaesthesia after arthroscopic shoulder surgery under preoperative interscalene nerve block or suprascapular + infraclavicular nerve block.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 76
• Est. completion date: April 1, 2020
• Est. primary completion date: March 1, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

• Patients scheduled for elective shoulder surgery under general anesthesia with suprascapular + infraclavicular nerve block or interscalene nerve block for any reason ASA 1-3 patients

Exclusion Criteria:

• Diabetes

• coagulopathy

• local anesthetic allergy

• chronic opioid users

• neurological deficit of the surgical limb

• obstructive or restrictive pulmoner disease

• inability to understand pain scores

Related Conditions & MeSH terms

• Arthroscopic Shoulder Surgery

Intervention

Other:
• Interscalene block
30 minutes before anaesthesia induction interscalene nerve block will be applied with ultrasound guidance with %0,25 bupivacain 20 cc .The sham block consisted of after patients were placed in the lateral decubitus position skin preparation, ultrasound scanning of the suprascapular region, and a dry-needling, all performed to preserve patient blinding in the ISB group patients.
• suprascapular and infraclavicular nerve block
30 minutes before anaesthesia induction suprascapular with %0,25 bupivacain 10 cc .and infraclavicular nerve block with %0,25 bupivacain 10 cc will be applied with ultrasound guidance

Locations

Country	Name	City	State
Turkey	Diskapi Yildiim Beyazit Eduation and Research Hospital	Ankara

Sponsors (1)

Lead Sponsor	Collaborator
Diskapi Yildirim Beyazit Education and Research Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	postoperative pain: numeric rating scale (NRS)	postoperative pain will be evaluated by numeric rating scale (NRS) .	postoperative 30. minute, 4. hour, 8.hour,12. hour, 24. hour, 48. hour
Secondary	phrenic nerve paralysis evaluated with ultrasound	Thirty minutes after the block, M-mode ultrasound examination of the ipsilateral hemidiaphragm was performed to measure diaphragmatic excursion.	thirty minutes after the nerve block